New England Biolabs announces the release of its Monarch Mag Viral DNA/RNA Extraction Kit. This extraction kit enhances recovery of low amounts of viral nucleic acid to enable highly sensitive detection. The kit uses a magnetic bead-based process to extract viral RNA and DNA reproducibly and efficiently, while enabling...
Roche announced that its Elecsys pTau217 assay received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). This blood test, which is being developed in collaboration with Eli Lilly and Company, will be used to help identify the presence or absence of amyloid pathology in individuals, which...
Charles River Laboratories International, Inc. announced the launch of Patholytix Foresight, a non-clinical artificial intelligence (AI) decision support tool developed in collaboration with Deciphex, an innovator in pathology AI. By combining Deciphex’s unique digital pathology solutions with Charles River’s robust non-clinical pathology programs, clients of both organizations will have...
Prenosis will collaborate with Roche to bring the Sepsis ImmunoScore™ to hospitals across the United States on Roche's navify® Algorithm Suite platform
Prenosis, Inc., an artificial intelligence company enabling precision medicine in acute care, announced a commercial distribution collaboration with Roche for its Sepsis ImmunoScore™, an artificial intelligence/machine learning software as a medical device (AI...
PredxBio, Inc., a leader in spatially intelligent biology, and PictorLabs, Inc., a leading digital pathology firm pioneering AI-powered virtual staining technology, are pleased to announce a transformative partnership aimed at revolutionizing cancer research, diagnosis, and treatment.
PredxBio, Inc., a leader in spatially intelligent biology, and PictorLabs, Inc., a leading digital...
InfoBionic.Ai continues to advance its mission of improving outcomes and enabling better cardiac care with a name that captures the essence of its next gen, AI-enabled virtual telemetry solution.
InfoBionic.Ai, a digital health company providing AI-powered diagnostic remote patient monitoring solutions, announced that it has evolved its company name from...
IQVIA, a leading global provider of data, analytics, technology and services to the life sciences industry, and Salesforce, the #1 AI CRM, announced an expanded global strategic partnership to accelerate the development of Salesforce’s Life Sciences Cloud, a next-generation customer engagement platform for the global life sciences industry.
Building on...
Tempus, a leader in artificial intelligence and precision medicine, will present new data along with Pfizer at the AACR 2024 Annual Meeting. The abstract, titled “Analysis of HER2 prevalence by RNA expression across solid tumors,” found that by correlating HER2 protein levels by IHC/ISH and ERBB2 mRNA levels by...
Tempus, a leader in artificial intelligence and precision medicine, is broadly introducing its new Workspaces feature in the Lens platform. Workspaces is a private, coding-based cloud environment designed to unblock research and accelerate innovation. This new interface provides researchers a frictionless workflow for surfacing critical insights to power scientific...
Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic outcomes, will showcase its developments in cancer research and diagnostics at the American Association for Cancer Research (AACR) Annual Meeting in San Diego, California from April 5-10, 2024. Nucleai's...
